The timing of hormone therapy for men with asymptomatic advanced prostate cancer

Author： Messing E.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.4, 2003-07, pp. : 245-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatigue in patients with prostate cancer receiving hormone therapy

By Stone P.   Hardy J.   Huddart R.   A'Hern R.   Richards M.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1134-1141

Elsevier

Access to resources Recommend Favorite

Intermittent Androgen Deprivation Therapy in Advanced Prostate Cancer

By Alva Ajjai   Hussain Maha  

Current Treatment Options in Oncology, Vol. 15, Iss. 1, 2014-03 ,pp. : 127-136

Springer Publishing Company

Access to resources Recommend Favorite

The nutritional status of older men with advanced prostate cancer and factors affecting it

By Toliusiene Jolanta  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 716-719

Springer Publishing Company

Access to resources Recommend Favorite

Hormone Resistance in Prostate Cancer

By Pilat M.J.P.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 4, 1998-01 ,pp. : 373-381

Springer Publishing Company

Access to resources Recommend Favorite

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer

By See William   Tyrrell Chris  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 1, 2006-08 ,pp. : 7-16

Springer Publishing Company

Access to resources Recommend Favorite